Back
Inventiva SA 10K Form
Sell
37
IVA
Inventiva SA
Last Price:
2.76
Seasonality Move:
2.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IVA News And Ratings
See the #1 stock for the next 7 days that we like better than IVA
IVA Financial Statistics
Sales & Book Value
Annual Sales: | $18.92M |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $-1.62 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -2.21830 |
---|---|
Net Income (TTM): | $-112.19M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | -171.62% |
Inventiva SA Earnings Forecast
Key Inventiva SA Financial Ratios
- The Research & Development expenses have been 629.47% of Revenue.
- The Interest Expense is -4.69% of Operating Income.
- The Net Earning history of IVA is -631.84% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Inventiva SA Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | IVA |
Website: | inventivapharma.com |
Debt
Debt-to-Equity Ratio: | -0.59 |
---|---|
Current Ratio: | 0.59 |
Quick Ratio: | 0.43 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
IVA Technical Analysis vs Fundamental Analysis
Sell
37
Inventiva SA (IVA)
is a Sell
Is Inventiva SA a Buy or a Sell?
-
Inventiva SA stock is rated a Sell
The current Inventiva SA [IVA] share price is $2.76. The Score for IVA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.